A review of current and emerging treatments for diabetic macular oedema and macular oedema sec...
5 September 2012
Volume 13, Issue 3
A discussion of current and emerging treatments for diabetic retinopathy, diabetic maculopathy, central retinal vein occlusion and branch retinal vein occlusion.
Introduction
With the number of people having diabetes set to increase significantly, the burden of treating the complications of diabetic retinopathy is a major concern for the future. Retinal vein occlusion is an important cause of visual loss, particularly in elderly patients. With an ageing population, retinal vein occlusion is likely to become more common. This review discusses current treatments and emerging treatments for diabetic retinopathy, diabetic maculopathy, central retinal vein occlusion and branch retinal vein occlusion. It is essential that community optometrists keep up to date with new treatments and be aware of when patients should be optimally referred.
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Sean Matthews Mackie FCOptom discusses a case of the rare systemic disorder PXE, which can put patients at higher risk of vascular disease and choroidal neovascularisation, and is diagnosed in part through retinal examination.
A glance at what’s happening in the world of technology.
Optometric management of pregnant women requires a careful balance between effective treatment and ensuring the safety of both the mother and baby, writes Becky McCall.